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Abstract. We have cloned the complete coding region of the
porcine TNFSF10 gene. The porcine TNFSF10 cDNA has an
ORF of 870 nucleotides and shares 85% identity with human
TNFSF10, and 75% and 72% identity with rat and mouse
Tnfsf10 coding sequences, respectively. The deduced porcine
TNFSF10 protein consists of 289 amino acids with the calcu-
lated molecular mass of 33.5 kDa and a predicted pI of 8.15.
The amino acid sequence similarities correspond to 86, 72 and
70% when compared with human, rat and mouse sequences,
respectively. Northern blot analysis detected TNFSF10-spe-
cific transcripts (F1.7 kb) in various organs of a 10-week-old
pig, suggesting ubiquitous expression. Real-time RT-PCR stud-
ies of various organs from fetal (days 73 and 98) and postnatal
stages (two weeks, eight months) demonstrated developmental
and tissue-specific regulation of TNFSF10 mRNA abundance.
The chromosomal location of the porcine TNFSF10 gene was
determined by FISH of a specific BAC clone to metaphase
chromosomes. This TNFSF10 BAC clone has been assigned
to SSC13q34→q36. Additionally, the localization of the
TNFSF10 gene was verified by RH mapping on the porcine
IMpRH panel.
Copyright © 2005 S. Karger AG, Basel
TNF·-related apoptosis-inducing ligand (TRAIL/Apo-2L)
is encoded by the tumor necrosis factor superfamily member 10
gene (TNFSF10). Currently over 40 distinct ligand-receptor
systems of this superfamily are recognized in human. In pig,
the positions of TNFSF1A and TNFSF1B were mapped to
7p11→q11 (Solinas et al., 1992). Sequence information of
three other genes, TNFSF4–6, is available in public databases
along with a growing number of porcine transcripts showing
high homologies to human TNF ligand superfamily members.
TRAIL has been shown to be important for the control of
tumor growth and for modulation of the cellular immune sys-
tem. An apoptosis-inducing effect of TRAIL was observed pri-
marily in tumor cells and in Jurkat human T cells. This effect is
initiated by binding of TRAIL to receptors TRAIL-R1 (DR4)
and TRAIL-R2 (DR5), which signal apoptosis via their cyto-
plasmic death domains (Pan et al., 1997a, b; Sheridan et al.,
1997). Other TRAIL binding proteins, TRAIL-R3 (DcR1),
TRAIL-R4 (DcR2), and osteoprotegerin, lack functional death
domains and have been discussed as decoy receptors (Degli-
Esposti et al., 1997; Marsters et al., 1997; Sheridan et al.,
1997).
Recent studies have shown that TRAIL is involved in the
mediation of cytotoxic effects of immune cells, including T-
cells, NK cells, macrophages and dendritic cells. Thus it has
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been suggested that TRAIL could play a role in suppressing
tumor metastasis. This assumption was supported by the obser-
vation of increased susceptibility to tumor initiation and me-
tastasis in TRAIL-deficient mice (Liu et al., 2001; Takeda et al.,
2001; Cretney et al., 2002).
In addition to its anti-tumor effects, various immune modu-
latory mechanisms of TRAIL have been described. TRAIL is
able to induce primary plasma cell apoptosis and to shorten the
lifespan of neutrophils (Ursini-Siegel et al., 2002; Renshaw et
al., 2003; Kamohara et al., 2004). Moreover TRAIL acts as a
cell cycle inhibitor for T-cells independent of their differentia-
tion status or antigen specificity (Song et al., 2000; Lunemann
et al., 2002). Recently TRAIL was reported to inhibit the pri-
marily T-cell mediated rejection of corneal allografts (Xie et al.,
2003). Thus, expression of human TRAIL in transgenic pigs
might be a strategy to protect pig tissues against cell-mediated
rejection after xenotransplantation to primates (Klose et al.,
2005). To further explore the feasibility of this approach, infor-
mation on sequence similarity and expression levels of the
endogenous TNFSF10 gene encoding TRAIL is necessary.
Therefore, we cloned the porcine TNFSF10 cDNA, determined
TNFSF10 mRNA levels in different tissues and at various
stages of development, and mapped the porcine TNFSF10 gene
to SSC13q34→q36.
Materials and methods
Cloning and sequencing of the porcine TNFSF10 cDNA sequence
PCR primers (TRAIL#4/TRAIL867 and TRAIL#7/TRAIL#6; all prim-
ers used in this study are listed in Table 1) were designed based on the
human, mouse and rat TNFSF10/Tnfsf10 cDNA sequences (DDBJ/EMBL/
GenBank database accession numbers U37518, U37522 and AY115578)
and used to amplify partial sequences of the porcine TNFSF10 cDNA.
TRAIL#5 was used as gene-specific primer in 3)-RACE using the SMART™
RACE cDNA Amplification Kit (BD Clontech, Mountain View, CA) accord-
ing to the manufacturer’s instructions. 5)-RACE was performed using a stan-
dard protocol (Sambrook and Russell, 2001) and the gene-specific primers
TRAIL#12 and TRAIL#13 as well as the adapter primers Ad and Ad20T.
PCR products were cloned using the TOPO TA Cloning® Kit (Invitrogen,
Karlsruhe, Germany) and sequenced.
Quantitative RT-PCR analysis of TNFSF10 expression
Total RNA of liver, lung and kidney of fetuses and pigs of different ages
was extracted using TRIZOL reagent (Invitrogen) following the manufactur-
er’s instructions. RNA quality was checked by gel electrophoresis before and
after DNase digestion. Reverse transcription was performed using 400 ng
total RNA, 3 Ìg hexamer primers, 10 mM DTT, 40 units RNaseOut (Invi-
trogen) and 200 units Superscript II reverse transcriptase (Invitrogen) at
42 °C for 50 min. After termination at 70 ° C for 15 min, samples were stored
at –80 ° C.
Primers for a housekeeping gene (H2A_se and H2A_as, Table 1) were
designed from the bovine histone 2A (H2A) sequence (accession
NM_174809) and used as internal control. Primers TRAIL#5 and TRAIL#6
were used for the amplification of a TNFSF10 cDNA fragment (Table 1).
Quantification of mRNA abundance was performed by real-time PCR detec-
tion using an ABI PRISM 7700 sequence detector (Applied Biosystems, Wei-
terstadt, Germany) and SybrGreen® as a double stranded DNA-specific fluo-
rescent dye. Amplification mixes (25 Ìl) contained 2 Ìl cDNA, 12.5 Ìl Sybr-
Green PCR Mix, 0.25 Ìl IU AmpErase uracil N-glycosylase (all from Applied
Biosystems), 1.5 Ìl of each primer (300 nM finally), and 7.25 Ìl water. The
standard curve was performed using plasmids with the sequences of the
selected genes, and six serial dilutions (1:5) were used for all selected genes
ranging from 1 million to 320 copies. The abundance of TNFSF10 mRNAs
was calculated using the standard curve method, with determination of PCR
Table 1. Primers used in this study
Primer Orientation Sequence (5’-3’) 
TRAIL867 reverse TAA AAA GGC CTCC
A
GAA 
A
GAA 
A
GCT GGC TTC 
TRAIL #5 forward TGG ACA AGC TAT CCT GAC CCT ATA C 
TRAIL #6 reverse CAC CTT GAT AGA TGG AAT AGA GTC C 
TRAIL #12 reverse TCA CAA ACT GAC GTA GCT GCC AC 
TRAIL #13 reverse TCA TCA GCA GTA TAG GGT CAG 
AdT20 forward ATT GAA TTC TCT AGA ACG CGT CTC GAG (T)20
Ad forward ATT GAA TTC TCT AGA ACG CGT CTC GAG 
H2A_se forward TGC TGG TGG TGG TGT CAT TC 
H2A_as reverse CCA GGC ATC CTT TAG ACA GTC TTC T 
TNFSF10_F forward TCA ACC CAA AGG CTC AAC 
TNFSF10_R reverse CAG TGC TGC CCT TTT CTC 
amplification efficiency and normalization for H2A mRNA as the internal
reference.
QPCR was started with 2 min at 50 °C for AmpErase activation and
10 min at 95 ° C for denaturation. The program continued with 40 cycles of
15 s at 95 °C and 30 s at 60 ° C and 30 s at 72 °C. Each assay included tripli-
cates of cDNA.
Isolation and characterization of a genomic TNFSF10 clone
A genomic DNA clone (RP44-472G15) of approximately 165 kb was iso-
lated from the porcine RPCI-44 BAC library after screening high density
BAC filters according to the RPCI protocols (http://www.chori.org/bacpac/).
A 32P-labeled 279-bp PCR product from the porcine TNSF10 gene was used
as probe. The PCR primers for this product were TNFSF10_F and
TNFSF10_R (Table 1). DNA of the BAC clone RP44#472G15 was isolated
using the Qiagen plasmid midi kit (Qiagen, Hilden, Germany). BAC ends
were sequenced with the ThermoSequenase kit (Amersham Biosciences,
Freiburg, Germany) on a LI-COR 4200L-2 automated sequencer (MWG
Biotech, Ebersberg, Germany). The end sequences were deposited under
accessions AJ786143 and AJ786144 in the EMBL nucleotide database.
Fluorescence in situ hybridization (FISH) analysis
The porcine genomic BAC clone RP44-472G15 containing the porcine
TNFSF10 gene was labeled with digoxigenin by nick translation using a
Nick-Translations-Mix (Roche, Mannheim, Germany). FISH on GTG-
banded pig chromosomes was performed using 750 ng of digoxigenin-labeled
BAC DNA. In this experiment 24 Ìg sheared total porcine DNA and 10 Ìg
salmon sperm were used as competitors. After hybridization over night, sig-
nal detection was performed using a digoxigenin-FITC detection kit (Quan-
tum Appligene, Heidelberg, Germany). The chromosomes were counter-
stained with DAPI and propidium iodide and embedded in antifade solu-
tion. Thirty metaphases that had previously been photographed were re-
examined after hybridization with a Zeiss Axioplan 2 microscope equipped
for fluorescence.
Probe description:
Probe name: RP44-472G15
Probe type: porcine genomic BAC clone
Insert size: 165 kb
Vector: pTARBAC2
Proof of authenticity: DNA sequencing and gene-specific PCR
Gene reference of human TNFSF10: Wiley et al., 1995
Radiation hybrid (RH) mapping
The primer pair TNFSF10_F and TNFSF10_R developed for the amplif-
ication of the TNFSF10 probe was also used for RH mapping. Amplification
of the marker was done on the INRA-Minnesota Porcine Radiation Hybrid
(IMpRH) panel (Yerle et al., 1998; Hawken et al., 1999) (http://imprh.tou-
louse.inra.fr/) as described previously (Leeb and Rohrer, 2002). The map-
ping tool at the IMpRH Server (Milan et al., 2000) was used for the mapping
of this new marker relatively to markers previously mapped on the IMpRH
panel. The order of markers already mapped on the first generation map is
considered as known. The two point option of the RHMAP3.0 package
(Lange et al., 1995) reveals two-point distances with flanking markers.
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Fig. 1. Deduced amino acid sequence of porcine TNFSF10 and alignment to the human, rat, and mouse TNFSF10 proteins,
respectively. The amino acid sequences for the human, rat, and mouse TNFSF10 were obtained from nucleotide sequences of the
DDBJ/EMBL/GenBank database (human: U37518; rat: AY115578; mouse: U37522). Asterisks and colons under the aligned
sequences indicate complete match and match among three species of four, respectively. The putative transmembrane anchor is
underlined in the human sequence. A conserved cysteine residue that is assumed to mediate zinc binding is indicated by a rhom-
bus.
Results and discussion
Porcine TNFSF10 cDNA sequence
To isolate the complete coding region of the porcine
TNFSF10 gene, RACE experiments and PCR were performed.
The cDNA has an ORF of 870 nucleotides. The sequence has
been deposited in DDBJ/EMBL/GenBank under accession
AY639873. The ORF has 85% identity to the TNFSF10 nucle-
otide sequences of human TNFSF10, 75 and 72% identity to
the nucleotide sequences of rat and mouse Tnfsf10, respective-
ly. The deduced porcine TNFSF10 protein consists of 289 ami-
no acids with a calculated molecular mass of 33.5 kDa and a
predicted pI of 8.15. At the amino acid level the porcine
TNFSF10 protein shows 86% similarity to human TNFSF10
and 72 or 70% to rat or mouse TNFSF10 amino acid
sequences, respectively (Fig. 1). The putative transmembrane
anchor for the porcine TNFSF10 protein comprises amino
acids 18–28 similar to human. Amino acids 172–188 match the
consensus sequence for the TNF type II membrane protein
family. The domain for metal binding is highly conserved
among pig, human, rat and mouse, with cysteine 230 (human)
as the putative zinc binding amino acid, required for activity
and trimerization of the TNFSF10 protein (Bodmer et al.,
2000; Hymowitz et al., 2000). The high degree of amino acid
identity between pig and human, especially in the C-terminal
domain of the TNFSF10 protein, suggests that the porcine pro-
tein might be able to interact with human TRAIL receptors.
Expression of the porcine TNFSF10 gene
The human gene for TNFSF10 is known to be ubiquitously
expressed in a large variety of adult tissues (Wiley et al., 1995).
To investigate expression of the porcine homolog, RT-PCR and
Northern blot experiments were performed using RNA isolated
from various tissues of a 10-week-old piglet. We detected
TRAIL transcripts of approximately 1.7 kb in spleen, lung, liv-
er, kidney, heart, testis, muscle and skin (data not shown). This
suggested ubiquitous expression of TNFSF10 mRNA in pig.
Highest expression levels were detected in spleen, liver and
lung. In addition, we used quantitative RT-PCR to investigate
TNFSF10 gene expression at two time points during fetal
development (day 73 and 98) and postnatally in 2-week-old
piglets and adult pigs (8 months). TNFSF10 transcript abun-
dance in liver, lung and kidney was monitored in relation to
histone 2A transcripts, considering histone 2A to be a constitu-
Cytogenet Genome Res 111:74–78 (2005) 77
Fig. 2. Expression analysis of the porcine TNFSF10 gene in fetal and
adult tissues. Relative abundances were calculated using the standard curve
method by dividing the copy numbers of TNFSF10 mRNA by the copy num-
bers of H2A mRNA. Bars represent means and standard deviations of the
different developmental ages. DG: day of gestation; n: number of animals
tested. (a) Kidney; (b) lung; (c) liver; P values: * ! 0.05, ** ! 0.01,
*** ! 0.0001.
Fig. 3. Chromosome assignment of the porcine TNFSF10 gene by FISH
analysis on a porcine metaphase spread. The digoxigenin labeled BAC clone
RP44-472HG15 containing the porcine TNFSF10 gene was hybridized to
GTG-banded metaphase chromosomes of a normal pig. Double signals indi-
cated by arrows are visible on both chromosomes 13q34→q36. The chromo-
somes were counterstained with propidium iodide and subsequently identi-
fied by DAPI staining.
tively expressed gene. We detected TNFSF10 transcripts in all
tissue samples analyzed showing that expression was not re-
stricted to postnatal life (Fig. 2). Whereas in kidneys and liver,
normalized TNFSF10 expression did not change during fetal
development and showed only moderate changes after birth,
we observed an increase of TNFSF10 mRNA levels in kidneys
and liver of 8-month-old pigs (Fig. 2a, c). In contrast, expres-
sion levels in lungs seemed to be regulated during fetal develop-
ment, showing a clear increase between mid- and late pregnan-
cy. Postnatally, expression levels in lungs increased slightly
above the high levels reached in late pregnancy, but declined in
adult animals (Fig. 2b). The explicit increase of expression lev-
els in fetal lung correlates with the saccular phase of lung devel-
opment in pig (Rüsse and Sinowatz, 1991). Parallel to differen-
tiation and growth of the bronchiolar and alveolar system, out-
growth of the vascular system in lung takes place. Since it was
suggested that TNFSF10 plays an important role in endothelial
cell migration, vessel tube formation and extracellular matrix
synthesis in lung fibroblasts (Yurovsky, 2003; Secchiero et al.,
2004), TNFSF10 might be involved in lung tissue differentia-
tion. Moreover, TNFSF10 expression was located in the medial
smooth cell layers of pulmonary arteries of mouse, rat and
human (Gochuico et al., 2000; Spierings et al., 2004), as well as
in the bronchial epithelium and alveolar septa in human (Spier-
ings et al., 2004). Probably increased expression levels of
TRAIL mRNA in pig are correlated with lung growth and dif-
ferentiation. Accordingly, this might explain the low expression
levels in fully grown animals observed in our analyses.
In liver, we observed continuous increase of TNFSF10
transcript levels after birth as well as in adult animals (Fig. 2c).
In mice up to 30–40% of liver natural killer (NK) cells were
shown to express Tnfsf10 constitutively (Ochi et al., 2004). If
this holds true also in swine, increasing TNFSF10 transcript
levels might be due to a continuous raise in the TNFSF10
expressing cell population of the growing liver. Moreover,
TNFSF10 expression on liver NK cells is upregulated by inter-
feron Á (Smyth et al., 2001). This cytokine is secreted among
others by macrophages and mononuclear cells of the liver in
response to infectious agents and bacterial endotoxins cleared
from portal blood. Microbial colonization of the gut starts
shortly after birth, so we suggest that TNFSF10 expression lev-
els rise strongly after activation of TNFSF10 expressing liver
NK cells early in postnatal life. Later on, the immune status of
the animals might be reflected in TNFSF10 expression levels.
Chromosomal assignment of the porcine TNFSF10 gene
The porcine BAC clone RP44-472G15 has been retrieved
from the RPCI-44 BAC library with a porcine TNSF10 cDNA
probe. Colony PCR indicated that the clone indeed contained
the desired insert. Additional support for the correct identity of
the BAC clone was gained by the analysis of the BAC end
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sequences. The T7 end sequence had a BLAST hit to the
human genome (build 34.3) at 173.48 Mb on HSA3 (E =
5 W10–13) while the SP6 end sequence had a BLAST hit at
173.68 Mb on HSA3 (E = 5 W10–13). Thus the BLAST hits of the
two porcine BAC end sequences bracketed the human
TNFSF10 gene at 173.54–173.56 Mb on HSA3. The chromo-
somal location of the porcine TNFSF10 gene was determined
to be at SSC13q34→q36 by FISH of the BAC clone to meta-
phase chromosomes (Fig. 3). Additionally, the localization of
the TNFSF10 gene was verified by RH mapping on the porcine
IMpRH panel. The RH results were submitted to the IMpRH
database (http://imprh.toulouse.inra.fr). Two-point analysis
(Wiley et al., 1995) revealed that TNFSF10 is linked to the
marker IMpRH00891 on SSC13 with a distance of 18 cR and a
two-point Lod score of 14.89. The RH results were thus consis-
tent with the cytogenetic localization of TNFSF10 at
SSC13q34→q36. The human TNFSF10 ortholog is located on
HSA3q26 (Wiley et al., 1995). The chromosomal locations of
the rodent Tnfsf10 genes are MMU3A3 for the mouse and
RNO2q24 for the rat (http://www.ncbi.nlm.nih.gov/mapview).
These localizations correspond well to the synteny data of the
porcine RH map (Rink et al., 2002).
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